† Lomitapide Hepatic Safety: A Long-Term Retrospective Analysis in Patients with Homozygous Familial Hypercholesterolaemia

Lomitapide is a microsomal triglyceride transfer protein inhibitor for patients with homozygous familial hypercholesterolaemia (HoFH). Due to its mechanism of action, potential hepatic effects of lomitapide are of clinical interest.

Source: Journal of Clinical Lipidology - July 1, 2023 Category: Lipidology Authors: Dominique Larrey, Sallyann O'Brien, Laura D'Erasmo, Marcello Arca Tags: Genetic Disorders Source Type: research